IDS provides laboratories worldwide with clinical and research solutions in the field of specialty endocrinology. We aim to enhance laboratory efficiency, improve diagnostic accuracy and enrich diagnostic outcomes for patients.
We develop, manufacture and market innovative immunoassays and automated immunoanalyser technologies to provide improved diagnostic outcomes for patients. Our immunoassay portfolio is a combination of an endocrinology specialty testing menu and assay panels in autoimmunity, infectious diseases and allergy.
Immunodiagnostic Systems Holdings PLC (hereafter referred to as IDS) is a leading in-vitro diagnostic solution provider to the clinical laboratory market. IDS was founded in 1977 and trades on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. We are a global company headquartered in the UK with around 275 employees worldwide. Our products are developed and manufactured at our facilities in Europe. We serve our customers through regional offices in Europe and the USA, and have sales offices in Brazil. Our network of distributors works on our behalf to serve our customers throughout the rest of the world.
Our Global Headquarters are in the UK – and we have direct sales offices in Brazil, France, Germany and the USA. Our key manufacturing sites are based in Belgium, France, Italy and the UK. Our network of distributors support us in reaching clients worldwide with our innovative specialty immunoassay solutions.
View contact details for your area, by selecting from the drop-down menu, or clicking on the map.